Cognition Therapeutics Reports Year End 2021 Financial Results

by Sofia Fund | Mar 30, 2022 | Portfolio Company News

Read full Press Release here.

Older post: Cognition Therapeutics has a transformative 2021 with positive performance addressing age related degenerative diseases and disorders of the central nervous system.

Newer post: ACA Honors Angel-Financed Innovation with the Prestigious Luis Villalobos Award